health care

sector closed the day up 1.9%.

Cormedix Inc




Gentiva Health Services Inc




Amedisys Inc



), and

Uluru Inc



) were all decliners today within the health care sector with

Theragenics Corporation



) being today's featured health care loser. Theragenics Corporation fell one cent (-0.8%) to $1.25 on light volume. Throughout the day, 22,598 shares of Theragenics Corporation exchanged hands as compared to its average daily volume of 51,500 shares.

Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical products markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. Theragenics Corporation has a market cap of $45.5 million and is part of the

health services

industry. The company has a P/E ratio of 16.8, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 16.6% year to date as of the close of trading on Monday.

TheStreet Ratings rates Theragenics as a


. The company's strengths can be seen in multiple areas, such as its increase in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow.

On the positive front,

Transcept Pharmaceuticals Inc




Mela Sciences Inc




World Heart Corporation



), and

Tranzyme Inc



) were all gainers within the health care sector with

Bristol-Myers Squibb Company



) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care